Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

IOXILAN for Percutaneous coronary intervention: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 19 adverse event reports in the FDA FAERS database where IOXILAN was used for Percutaneous coronary intervention.

Most Reported Side Effects for IOXILAN

Side Effect Reports % Deaths Hosp.
Urticaria 36 30.3% 0 4
Vomiting 19 16.0% 0 0
Pruritus 16 13.5% 1 1
Nausea 15 12.6% 0 0
Hypersensitivity 12 10.1% 0 1
Rash 11 9.2% 0 2
Contrast media reaction 8 6.7% 1 0
Dyspnoea 8 6.7% 1 2
Sneezing 8 6.7% 0 1
Throat tightness 8 6.7% 0 2
Chest pain 7 5.9% 0 3
Hypotension 5 4.2% 1 2
Post procedural haematoma 5 4.2% 0 5

Other Indications for IOXILAN

Computerised tomogram (41) Angiogram (7)

Other Drugs Used for Percutaneous coronary intervention

PRASUGREL (376) CLOPIDOGREL BISULFATE (356) TICAGRELOR (297) ASPIRIN (227) BIVALIRUDIN (159) CANGRELOR (94) HEPARIN (86) ABCIXIMAB (49) INVESTIGATIONAL PRODUCT (46) IODIXANOL (29)

Related Pages

IOXILAN Full Profile All Percutaneous coronary intervention Drugs IOXILAN Demographics IOXILAN Timeline